Heart Failure Risk Reduction in Diabetes: What the Practicing Endocrinologist Should Know

Expert faculty discuss the latest data on using SGLT2 inhibitors to reduce HF risk in patients with T2D
Jennifer B. Green, MD
Mikhail N. Kosiborod, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.16 MB
Released: June 7, 2021

Acknowledgements

Provided by the Endocrine Society

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an independent educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company

Related Content

Video from Clinical Care Options (CCO): metabolic adaptations in obesity, value of sustained weight loss, and latest evidence for incretin-based therapies: semaglutide, tirzepatide, and mores

Randy J. Seeley, PhD Jenny Tong, MD, MPH Kristina M. Utzschneider, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: July 26, 2021 Expired: July 25, 2022

Clinical Care Options (CCO) presents Dr. George L. Bakris answering common questions about renoprotection strategies in CKD in T2D

George Bakris, MD Released: July 23, 2021

Practicing Clinicians Exchange presents Fatima Cody Stanford, MD, MPH, MPA, MBA, answering commonly asked questions about the use of GLP-1 receptor agonist pharmacotherapy in obesity management.

person default Fatima Cody Stanford, MD, MPH, MPA, MBA Released: July 22, 2021

Video from Clinical Care Options (CCO) and Stephen A. Harrison, MD: Emerging treatments for NASH and measuring hepatic and extrahepatic outcomes

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 20, 2021 Expired: July 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue